Conformationally restricted analogs of somatostatin with high μ-opiate receptor specificity

J. T. Pelton, K. Gulya, V. J. Hruby, S. P. Duckles, H. I. Yamamura

Research output: Contribution to journalArticlepeer-review

109 Scopus citations


A series of cyclic, conformationally restricted analogs of somatostatin have been prepared and tested for their ability to inhibit the binding of [3H]naloxone and [D-Ala2, D-Leu5][3H]enkephalin to rat brain membranes. The most potent analog, D-Phe[Cys-Tyr-D-Trp-Lys-Thr-Pen]-Thr-NH2 where Pen is penicillamine in [D-Phe5,[Cys6, Tyr7, D-Trp8, Pen11]]somatostatin-(5-12)-octapeptide amide, exhibited high affinity for μ-opiate receptors (IC50 value of [3H]naloxone = 3.5 nM), being 7800 times more potent than somatostatin. The cyclic octapeptide also displayed high μ-opiate receptor selectivity with an IC50 ([D-Ala2-, D-Leu5]enkephalin)/IC50 (naloxone) ratio of 271. The high affinity and selectivity of the somatostatin analog for μ-opiate receptors may be of use in examining the physiological role(s) of the μ-opiate receptor.

Original languageEnglish (US)
Pages (from-to)236-239
Number of pages4
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number1
StatePublished - 1985

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Conformationally restricted analogs of somatostatin with high μ-opiate receptor specificity'. Together they form a unique fingerprint.

Cite this